Free FRCS Section 1 sample questions

The inferior epigastric vessels are the surgeon's landmark dividing the two inguinal hernia types. The deep (internal) ring — an opening in transversalis fascia at the midpoint of the inguinal ligament — lies lateral to the inferior epigastric vessels; an indirect hernia enters it, travels within the coverings of the spermatic cord along the canal, and can descend to the scrotum. It follows the path of the processus vaginalis and is the type that presents in the young as well as the old. A direct hernia is an acquired weakness: it bulges forward through the posterior wall of the canal medial to the inferior epigastric vessels, through Hesselbach's (the inguinal) triangle — bounded laterally by the inferior epigastric vessels, medially by the lateral edge of rectus abdominis, and inferiorly by the inguinal ligament — lying outside the cord coverings, and rarely reaching the scrotum. At operation (or laparoscopy, where the vessels are seen directly on the posterior wall), the sac's relation to these vessels makes the diagnosis; both types are repaired by mesh reinforcement of the posterior wall, so the distinction is anatomical understanding more than a change of operation.

Why the others are wrong: A and E — lateral-to-vessels through the deep ring defines indirect; direct hernias push through the triangle and essentially never traverse the deep ring to the scrotum. B — the deep ring is lateral to the vessels. C — the femoral vein bounds the femoral canal, not Hesselbach's triangle.

Key point: Indirect = lateral to the inferior epigastric vessels, through the deep ring, within cord coverings, can reach the scrotum; direct = medial to the vessels, through Hesselbach's triangle (epigastrics laterally, rectus medially, inguinal ligament below) — the vessels are the dividing landmark at open and laparoscopic repair alike.

Guidelines: HerniaSurge International groin hernia guidelines 2018: sound repair rests on this anatomy — mesh repair (open Lichtenstein or laparo-endoscopic) is recommended for most adult inguinal hernias, with the myopectineal orifice fully assessed at minimal-access repair.

The femoral sheath — a prolongation of transversalis and iliac fascia beneath the inguinal ligament — contains the femoral artery, vein and, most medially, the femoral canal: a centimetre of loose areolar tissue and Cloquet's node that acts as dead space for venous expansion. Its ring is bounded by the inguinal ligament in front, pectineus and the pectineal ligament behind, the femoral vein laterally, and — the defining feature — the crescentic, unyielding free edge of the lacunar ligament medially. A hernia forcing itself through this small, rigid, three-quarters-ligamentous ring is gripped at the neck: femoral hernias have the highest strangulation rate of any groin hernia (a third or more presenting as emergencies, typically in elderly women — the anatomy behind the elderly-woman-with-a-groin-lump-and-obstruction vignettes elsewhere in this bank). At operation, releasing a strangulated hernia may require careful division of the lacunar ligament medially — with the classical caution that in a significant minority an aberrant obturator artery (the 'corona mortis', from the inferior epigastric) arches across it, and blind division invites serious haemorrhage. Surface anatomy separates it from the inguinal hernia: femoral emerges below and lateral to the pubic tubercle; inguinal above and medial.

Why the others are wrong: B and D — the canal is the most medial sheath compartment, bounded laterally by the vein. C — the femoral nerve lies outside (lateral to) the sheath. E — above-and-medial describes the inguinal hernia.

Key point: The femoral canal — inguinal ligament anteriorly, pectineal ligament posteriorly, femoral vein laterally, lacunar ligament's rigid edge medially — strangulates hernias at its unyielding ring; it emerges below and lateral to the pubic tubercle, and the lacunar ligament is divided warily for the corona mortis.

Guidelines: HerniaSurge International groin hernia guidelines 2018: the narrow, rigid femoral canal explains the high strangulation risk — femoral hernias are repaired promptly even when asymptomatic, and a low threshold for emergency repair applies in women.

Cardiac output (~5 L/min at rest) is the product of rate and stroke volume, and stroke volume's three determinants organise every haemodynamic decision in theatre and intensive care. Preload — the ventricular end-diastolic volume or wall stretch — sets the starting sarcomere length: the Frank-Starling mechanism means greater diastolic filling generates greater force of contraction (length-tension optimisation of actin-myosin overlap plus length-dependent calcium sensitivity), so the heart automatically ejects what it receives, matching the two ventricles' outputs beat by beat. The curve's shape carries the clinical meaning: on its steep ascending limb, volume raises output — the fluid-responsive patient; on the plateau, further filling adds only congestion — the physiology formalised by the passive leg raise and stroke-volume-variation testing in this bank's critical care section. Afterload — the load resisting ejection, approximated by systemic vascular resistance and aortic impedance — inversely affects stroke volume, most punishingly in the failing ventricle (why vasodilators help cardiogenic failure and why cross-clamping the aorta stresses the heart). Contractility — the inotropic state at any given load, set by sympathetic drive, calcium handling and drugs (catecholamines up; acidosis, hypoxia, beta-blockade down) — shifts the whole curve up or down: the failing septic or ischaemic heart operates on a flattened, downshifted curve, the rationale for inotropes when volume and pressure are optimised but output is not.

Why the others are wrong: A, B, C and E — stroke volume matters as much as rate; Starling describes stronger contraction with (physiological) stretch; pre- and afterload are distinct loading conditions; contractility is load-independent and drug- or state-modified, not fluid-modified.

Key point: Output = rate × stroke volume; stroke volume = preload (Starling's steep limb vs plateau — the whole basis of fluid-responsiveness testing), afterload (resistance to ejection) and contractility (the curve's position) — locate the patient on the curve before choosing fluid, vasopressor or inotrope.

Oxygen delivery = cardiac output × arterial oxygen content, and content is almost all haemoglobin-bound (1.34 mL O₂ per gram at full saturation — around 200 mL/L — versus ~3 mL/L dissolved), which is why anaemia and low output starve tissues despite a perfect PaO₂. The dissociation curve's sigmoid shape comes from cooperativity: each oxygen bound increases affinity for the next, giving a flat association plateau above ~8 kPa (loading is secure across a wide PaO₂ range — but equally, saturation stays deceptively high until PaO₂ falls onto the steep part, so a falling SpO₂ is a late alarm) and a steep unloading segment at tissue tensions. Shifts encode physiology: rightward — acidosis and CO₂ (the Bohr effect: exercising, hypercapnic tissue plucks oxygen off), fever, and raised 2,3-DPG (chronic hypoxia, anaemia) — favour unloading; leftward — alkalosis, hypothermia, depleted 2,3-DPG (stored bank blood transiently unloads poorly until DPG regenerates), fetal haemoglobin (placental extraction), and carboxyhaemoglobin — favour retention. Carbon monoxide is the double poison: 200-plus-fold haemoglobin affinity displaces oxygen AND left-shifts the remaining curve, while PaO₂ — dissolved oxygen — reads normal and standard two-wavelength pulse oximetry reads carboxyhaemoglobin as if oxygenated: the burns-and-inhalation patient (Parkland scenario elsewhere) needs co-oximetry and high-flow oxygen regardless of the numbers.

Why the others are wrong: B, C, D and E — haemoglobin carries the load; right shift lowers affinity to release oxygen; stored blood is DPG-depleted and left-shifted; oximetry is blinded by COHb.

Key point: Content lives on haemoglobin, and the sigmoid curve's shifts are delivery physiology — right (acid, CO₂, heat, DPG) unloads, left (alkalosis, cold, stored blood, CO, HbF) withholds; carbon monoxide poisons with a normal PaO₂ and a lying oximeter, and the flat plateau makes SpO₂ a late warning of hypoxaemia.

Guidelines: BTS emergency oxygen guidelines 2017: oxygen delivery depends on haemoglobin saturation, not dissolved oxygen — hence target saturations 94-98% (88-92% in hypercapnic risk), and 15 L/min via reservoir mask for carbon monoxide poisoning despite a normal PaO₂.

Acute inflammation is the body's emergency service, and its steps map onto the cardinal signs taught since Celsus. Vascular phase: momentary arteriolar constriction, then sustained vasodilatation driven by histamine (mast cells), prostaglandins and nitric oxide — hyperaemia producing redness (rubor) and heat (calor); simultaneously venular endothelial cells contract, opening intercellular gaps: protein-rich fluid (exudate — protein above ~30 g/L with cells, distinguishing it from the low-protein transudate of pure pressure/oncotic imbalance, the distinction used in effusion and ascites analysis) pours into tissue, causing swelling (tumor), diluting toxins and delivering fibrin, complement and antibodies. Pain (dolor) is mediated — bradykinin and PGE2 sensitise nociceptors (the pharmacological address of NSAIDs) — plus tension from swelling; together with reflex guarding these produce loss of function (functio laesa), which is real and protective. Cellular phase: slowed flow lets neutrophils marginate; selectins roll them, chemokine-activated integrins bind them firmly (ICAM/VCAM), they transmigrate (diapedesis) and follow chemotactic gradients — C5a, leukotriene B4, IL-8, bacterial peptides — to the focus, where opsonisation (IgG, C3b) enables phagocytosis and killing by the NADPH-oxidase respiratory burst and lysosomal enzymes (the mechanism whose failure — diabetes, hypothermia, steroids — explains this bank's wound infection risk factors). Outcomes: complete resolution; organisation and fibrosis; suppuration — the walled abscess whose antibiotic-impenetrability underlies the source-control doctrine; or transition to chronic inflammation.

Why the others are wrong: A, B, C and E — inflammation is protective (its absence, as in neutropenia, is deadly, and its signs are then muted); neutrophils arrive first (lymphocytes belong to chronicity); exudate is protein-rich and permeability-driven; functio laesa has mechanistic grounding.

Key point: Vasodilatation (rubor, calor), permeable venules leaking protein-rich exudate (tumor), mediator-sensitised pain (dolor) and neutrophils delivered by the selectin-integrin-chemotaxis relay — acute inflammation's machinery explains the cardinal signs, the exudate/transudate divide, and why pus needs a drain, not just a drug.

Chronic inflammation is not prolonged acute inflammation but a different programme, and its histology changes surgical diagnoses. Cellular cast: macrophages — recruited monocytes activated classically by T-cell interferon-gamma — dominate, flanked by lymphocytes and plasma cells; the tissue shows the signature paradox of destruction (macrophage enzymes, reactive oxygen species) proceeding alongside attempted repair — angiogenesis, fibroblast proliferation, collagen: the fibrosis that is chronic inflammation's monument (the strictures of Crohn's disease, the contracted gallbladder of chronic cholecystitis, the frozen fields of chronic pancreatitis met throughout this bank). Causes: persistent low-virulence infection (TB, H. pylori — whose gastritis-to-cancer sequence appears elsewhere), indigestible material (suture, mesh, urate, silica), and autoimmunity. The granuloma is the specialised solution to the indigestible: a organised focus of epithelioid macrophages (secretory, adherent transformation), often fused into Langhans-type giant cells, ringed by lymphocytes — immunological quarantine, T-cell-dependent (which is why anti-TNF therapy dissolves granuloma integrity and reactivates TB, the screening rationale before biologics in the Crohn's questions). Reading granulomas surgically: central caseous necrosis points to mycobacteria (the terminal-ileal or nodal TB masquerading as Crohn's or malignancy — send tissue for culture and PCR, not just formalin); non-caseating granulomas suggest Crohn's disease (a diagnostic criterion in the resected specimen), sarcoidosis, foreign-body reaction or vasculitides. The practical rule embedded here: unexpected granulomas in a surgical specimen mandate fresh-tissue microbiology and a TB question before immunosuppression.

Why the others are wrong: B, C, D and E — the cellular programme differs; granulomas are macrophage, not neutrophil, structures; caseation flags TB, its absence the others; fibrosis is chronicity's hallmark companion.

Key point: Chronic inflammation = mononuclear cells destroying and repairing at once, ending in fibrosis; the granuloma is T-cell-orchestrated macrophage quarantine — caseating: think TB (culture the tissue), non-caseating: think Crohn's, sarcoid or foreign body — and anti-TNF therapy unlocks the quarantine.

Guidelines: NICE tuberculosis guidance (NG33): granulomatous inflammation on histology should prompt fresh (unfixed) tissue for mycobacterial culture and molecular testing, since caseating granulomas suggest TB and culture confirms sensitivity — fixation destroys the organism's viability.

The wound classification is surgery's oldest risk model and still frames antibiotic and closure decisions. Clean: no entry into respiratory, alimentary, genitourinary tracts, no inflammation, asepsis unbroken — thyroidectomy, hernia repair; baseline infection 1 to 2% (rising with patient factors — the diabetes, smoking, obesity themes of the SSI bundle — and justifying prophylaxis only when a prosthesis makes rare infection catastrophic, per the mesh question). Clean-contaminated: a hollow viscus opened in a controlled fashion without unusual spillage — elective cholecystectomy, prepared colorectal resection, gastric and gynaecological surgery; around 5 to 10%, the category where timed antibiotic prophylaxis earns most of its living. Contaminated: gross gastrointestinal spillage, entry through acutely inflamed non-purulent tissue, major breaks in technique, and fresh (

Why the others are wrong: A, B, C and E — risk is class-dependent; pus makes a wound dirty by definition; antibiotics reduce but never reclassify risk; clean wounds still infect at low rates, and prosthetic implants justify prophylaxis there.

Key point: Clean (~1–2%), clean-contaminated (~5–10%), contaminated (~15–20%), dirty (~30–40%): the class predicts SSI, decides prophylaxis (single timed dose) versus treatment (continued course), and steers closure strategy — and a case can be upgraded by what happens on the table.

Guidelines: CDC/NHSN surgical wound classification, applied in NICE surgical site infection guidance (NG125): clean, clean-contaminated, contaminated and dirty classes predict infection risk and determine antibiotic prophylaxis versus treatment.

Empirical antibiotics are educated guesses, and the education is this map. Biliary tract: an obstructed duct breeds enteric organisms — Escherichia coli and Klebsiella dominate cholangitis and cholecystitis blood cultures, with Enterococcus a regular companion (relevant because cephalosporins miss it) and anaerobes joining after biliary-enteric anastomoses or stents: the piperacillin-tazobactam or cephalosporin-plus-metronidazole logic of the cholangitis question, always paired with the decompression that actually treats it. Colonic flora: the distal gut's ~10¹² organisms per gram are mostly anaerobes — Bacteroides fragilis the great abscess-former, its polysaccharide capsule orchestrating the walled-off collections of diverticular and appendiceal disease — mixed with coliforms and streptococci (Streptococcus anginosus/milleri group flagging abscesses anywhere): faecal peritonitis therefore always needs anaerobic cover (metronidazole) with Gram-negative cover, the composition behind every 'perforation' regimen in this bank. Skin and soft tissue: Staphylococcus aureus (coagulase-positive, abscess- and toxin-forming — wound infections, boils, line sepsis, and the MRSA variant with its decolonisation pathway) and the beta-haemolytic streptococci — Streptococcus pyogenes (group A) causing spreading cellulitis and erysipelas (dermal, sharply demarcated) and the type II monomicrobial necrotising fasciitis of the pain-out-of-proportion question, whose toxin production clindamycin suppresses. Hospital-acquired and critical-illness infection shifts right: Pseudomonas aeruginosa, ESBL and carbapenemase producers, enterococci and Candida (the upper-GI-perforation fungaemia lesson) — why ICU empirical regimens broaden and why cultures-then-de-escalation is stewardship's engine.

Why the others are wrong: B, C, D and E — flora is site-specific; B. fragilis is a gut anaerobe; cellulitis is streptococcal/staphylococcal; enterococci are habitual biliary residents.

Key point: Biliary = coliforms + enterococcus; colonic = coliforms + Bacteroides (metronidazole always); skin = Staph. aureus and group A strep (nec fasc's soloist); ICU = Pseudomonas, resistant Gram-negatives, Candida — empirical therapy is anatomy-guessed microbiology, corrected by cultures.

Guidelines: UKHSA Start Smart Then Focus: empirical antibiotic choice is built on the predictable flora of each site — enteric Gram-negatives and anaerobes for biliary and intra-abdominal sepsis, beta-haemolytic streptococci for cellulitis — refined by local policy and cultures.

Local anaesthetic pharmacology is arithmetic plus an emergency drill, and both are examinable. Mechanism: weak bases crossing the membrane un-ionised, then blocking voltage-gated sodium channels from within — smaller and myelinated fibres first (pain and temperature before touch and motor), and inflamed acidic tissue resisting (the ionised fraction rises — why abscess infiltration works poorly). Arithmetic: concentration to mass — a 1% solution is 10 mg/mL (0.25% = 2.5 mg/mL) — then dose to weight: lidocaine ~3 mg/kg plain (240 mg for 80 kg: 24 mL of 1%) and ~7 mg/kg with adrenaline 1:200,000, the vasoconstrictor slowing systemic absorption, prolonging block and reducing bleeding (traditional caution in digits, nose and penis persists in exams); bupivacaine ~2 mg/kg (longer-acting, motor-sparing at low concentrations — the wound-infiltration workhorse) with the crucial caveat of its cardiotoxicity: avid, slowly reversible cardiac sodium-channel binding means ventricular arrhythmia and arrest can PRECEDE neurological warning, why it is absolutely contraindicated in intravenous regional anaesthesia (Bier's block — prilocaine's territory) and why levobupivacaine exists. Toxicity (LAST) usually follows inadvertent intravascular injection or cumulative overdose: perioral paraesthesia, metallic taste, tinnitus, agitation → seizures → conduction block, arrhythmia, collapse. The drill: stop injecting, call for help, airway and 100% oxygen, benzodiazepines for seizures, ALS modified (avoid lidocaine as an anti-arrhythmic; prolonged resuscitation justified) — and the specific antidote: 20% lipid emulsion (Intralipid) bolus 1.5 mL/kg then infusion per AAGBI guideline, the 'lipid sink' every theatre and ED must stock and every surgeon infiltrating must know. Prevention completes it: aspirate before injecting, incremental dosing, know the running total across field blocks and infiltration.

Why the others are wrong: A, B, D and E — maxima are real and weight-based; 1% = 10 mg/mL; bupivacaine is the MOST cardiotoxic and banned from Bier's block; lipid emulsion is the rescue.

Key point: Sodium-channel blockers with hard ceilings — lidocaine 3 (plain)/7 (with adrenaline) mg/kg, bupivacaine 2 mg/kg, 1% = 10 mg/mL — LAST runs mouth-tingling → seizures → bupivacaine's early cardiac arrest, and the answer is stop, support, and 20% lipid emulsion by protocol.

Guidelines: AAGBI safety guideline on local anaesthetic systemic toxicity: calculate maximum doses before infiltration (lidocaine 3 mg/kg, 7 mg/kg with adrenaline; bupivacaine 2 mg/kg), and treat toxicity with immediate cessation, airway support and intravenous lipid emulsion per the published protocol.

The WHO checklist is the operating theatre's pre-flight discipline, and its three stations map to the moments where preventable harms are born. Sign in (before induction, with the anaesthetist and the awake patient wherever possible): identity, procedure and SITE against the consent form and the surgeon's mark — the wrong-site defence begins here — plus allergies (the anaphylaxis question's prevention arm), anticipated difficult airway or aspiration risk, and expected blood loss over 500 mL triggering access and cross-match readiness. Time out (the full team, before knife-to-skin): introductions by name and role — flattening the hierarchy so the most junior voice can later challenge; verbal re-confirmation of patient, procedure, site; ANTIBIOTIC PROPHYLAXIS within the prior 60 minutes (the checklist is the delivery vehicle for that pharmacokinetic rule); imaging displayed; and the anticipatory declarations — surgeon's critical steps and expected loss, anaesthetist's patient-specific concerns, nursing's sterility and equipment status — that convert individual awareness into team awareness. Sign out (before the patient leaves theatre): counts of instruments, swabs and needles reconciled (the retained-foreign-object barrier — its failure the Never Event of the governance question), specimen labelled and READ ALOUD (mislabelled specimens harm as surely as retained swabs — the pathology-handling question's first step), equipment failures logged, and the recovery and post-operative concerns verbally handed over. The evidence: the multicentre Haynes study nearly halved deaths and complications, with the caveat the exam likes — benefit tracks genuine engagement, not box-ticking — and NatSSIPs embed it, with LocSSIPs extending the same logic to every invasive procedure outside theatre (drains, blocks, endoscopy).

Why the others are wrong: A, C, D and E — mortality evidence exists and is trial-grade; time out precedes incision; counts and labelling are sign out; the checklist covers invasive procedures under any anaesthesia.

Key point: Sign in (identity, site, allergy, airway, blood) before induction; time out (team, confirmation, antibiotics ≤60 min, critical events) before incision; sign out (counts, labelled specimen read aloud, handover) before leaving — a communication tool with mortality evidence, not paperwork, and the carrier of half this bank's prevention rules.

Guidelines: WHO Surgical Safety Checklist (2009) and NatSSIPs 2: sign in, time out and sign out are team communication barriers proven to reduce deaths and complications — effectiveness depends on genuine engagement, with the whole team paused and contributing, not ritual box-ticking.